Recent advances in gene delivery for structural bone allografts

Tissue Engineering

Volumn 13, Issue 8, 2007, Pages 1973-1985

  Awad, Hani A ^a,b,c   Zhang, Xinping ^b,c   Reynolds, David G ^a,b,c   Guldberg, Robert E ^d   O'Keefe, Regis J ^b,c   Schwarz, Edward M ^b,c  

^a University of Rochester   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; GRAFTS; PATIENT TREATMENT; PROTEINS;

BONE MORPHOGENETIC PROTEINS (BMP); MESENCHYMAL STEM CELLS (MSC); NEOVASCULARIZATION; OSTEOINDUCTIVE SCAFFOLD MATERIAL;

GENE TRANSFER;

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CALCIUM PHOSPHATE; COLONY STIMULATING FACTOR 1; DOXYCYCLINE; HYDROXYAPATITE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOGENIC PROTEIN 1; PARVOVIRUS VECTOR; PROCOLLAGEN C PROTEINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; AUTOGRAFT; BONE ALLOGRAFT; BONE DEVELOPMENT; BONE GROWTH; BONE MINERAL; BONE PROSTHESIS; BONE REMODELING; BONE STRUCTURE; CALLUS; CORTICAL BONE; FEMUR; GENE TARGETING; GROWTH STIMULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TISSUE ENGINEERING; VIRUS RECOMBINANT;

ANIMALS; BONE AND BONES; BONE TRANSPLANTATION; GENE TRANSFER TECHNIQUES; HUMANS; TRANSPLANTATION, HOMOLOGOUS;

ADENO-ASSOCIATED VIRUS; MURINAE;

EID: 34548068563     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.0107     Document Type: Review

References (118)

1. Mankin, H.J., Gebhardt, M.C., Jennings, L.C., Springfield, D.S., and Tomford, W.W. Long-term results of allograft replacement in the management of bone tumors. Clin Orthop Relat Res 324, 86, 1996.
2. Jaffe, K.A., Morris, S.G., Sorrell, R.G., Gebhardt, M.C., and Mankin, H.J. Massive bone allografts for traumatic skeletal defects. South Med J 84, 975, 1991.
3. Mankin, H.J., Gebhardt, M.C., and Tomford, W.W. The use of frozen cadaveric allografts in the management of patients with bone tumors of the extremities. Orthop Clin North Am 18, 275, 1987.
4. Brigman, B.E., Hornicek, F.J., Gebhardt, M.C., and Mankin, H.J. Allografts about the knee in young patients with high-grade sarcoma. Clin Orthop Relat Res 421, 232, 2004.
5. Goldberg, V.M., and Stevenson, S. The biology of bone grafts. Semin Arthroplasty 4, 58, 1993.
6. Chalmers, J. Transplantation immunity in bone homografting. J Bone Joint Surg Br 41-B, 160, 1959.
7. Burchardt, H., Jones, H., Glowczewskie, F., Rudner, C., and Enneking, W.F. Freeze-dried allogeneic segmental cortical-bone grafts in dogs. J Bone Joint Surg Am 60, 1082, 1978.
8. Tomford, W.W., Mankin, H.J., Friedlaender, G.E., Doppelt, S.H., and Gebhardt, M.C. Methods of banking bone and cartilage for allograft transplantation. Orthop Clin North Am 18, 241, 1987.
9. Lord, C.F., Gebhardt, M.C., Tomford, W.W., and Mankin, H.J. Infection in bone allografts. Incidence, nature, and treatment. J Bone Joint Surg Am 70, 369, 1988.
10. Akkus, O., and Rimnac, C.M. Fracture resistance of gamma radiation sterilized cortical bone allografts. J Orthop Res 19, 927, 2001.
11. Vangsness, C.T., Jr., Garcia, I.A., Mills, C.R., Kainer, M.A., Roberts, M.R., and Moore, T.M. Allograft transplantation in the knee: tissue regulation, procurement, processing, and sterilization. Am J Sports Med 31, 474, 2003.
12. Vangsness, C.T., Jr., Triffon, M.J., Joyce, M.J., and Moore, T.M. Soft tissue for allograft reconstruction of the human knee: a survey of the American Association of Tissue Banks. Am J Sports Med 24, 230, 1996.
13. Boyce, T., Edwards, J., and Scarborough, N. Allograft bone. The influence of processing on safety and performance. Orthop Clin North Am 30, 571, 1999.
14. Berrey, B.H., Jr., Lord, C.F., Gebhardt, M.C., and Mankin, H.J. Fractures of allografts. Frequency, treatment, and end-results. J Bone Joint Surg Am 72, 825, 1990.
15. Hidaka, C., Cunningham, M.E., Rodeo, S.A., Maher, S.A., and Zhu, W. Modern biologies used in orthopaedic surgery. Curr Opin Rheumatol 18, 74, 2006.
16. Younger, E.M., and Chapman, M.W. Morbidity at bone graft donor sites. J Orthop Trauma 3, 192, 1989.
17. Summers, B.N., and Eisenstein, S.M. Donor site pain from the ilium. A complication of lumbar spine fusion. J Bone Joint Surg Br 71, 677, 1989.
18. Tiyapatanaputi, P., Rubery, P.T., Carmouche, J., Schwarz, E.M., O'Keefe, R.J., and Zhang, X. A novel murine segmental femoral graft model. J Orthop Res 22, 1254, 2004.
19. Burchardt, H. Biology of bone transplantation. Orthop Clin North Am 18, 187, 1987.
20. Burchardt, H. The biology of bone graft repair. Clin Orthop Relat Res 174, 28, 1983.
21. Einhorn, T. Mechanisms of fracture healing. Hosp Pract (Off Ed) 26 Suppl 1, 41, 1991.
22. Einhorn, T.A. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 355 Suppl, S7, 1998.
23. Friedlaender, G.E. Bone grafts. The basic science rationale for clinical applications. J Bone Joint Surg Am 69, 786, 1987.
24. Kerry, R.M., Masri, B.A., Garbuz, D.S., Czitrom, A., and Duncan, C.P. The biology of bone grafting. Instr Course Lect 48, 645, 1999.
25. Khan, S.N., Cammisa, F.P., Jr., Sandhu, H.S., Diwan, A.D., Girardi, F.P., and Lane, J.M. The biology of bone grafting. J Am Acad Orthop Surg 13, 77, 2005.
26. Carano, R.A., and Filvaroff, E.H. Angiogenesis and bone repair. Drug Discov Today 8, 980, 2003.
27. Stevenson, S., Emery, S.E., and Goldberg, V.M. Factors affecting bone graft incorporation. Clin Orthop Relat Res 324, 66, 1996.
28. Stevenson, S., Li, X.Q., Davy, D.T., Klein, L., and Goldberg, V.M. Critical biological determinants of incorporation of non-vascularized cortical bone grafts. Quantification of a complex process and structure. J Bone Joint Surg Am 79, 1, 1997.
29. Enneking, W.F., and Campanacci, D.A. Retrieved human allografts: a clinicopathological study. J Bone Joint Surg Am 83-A, 971, 2001.
30. Enneking, W.F., and Mindell, E.R. Observations on massive retrieved human allografts. J Bone Joint Surg Am 73, 1123, 1991.
31. Pelker, R.R., Friedlaender, G.E., and Markham, T.C. Biomechanical properties of bone allografts. Clin Orthop Relat Res 174, 54, 1983.
32. Wheeler, D.L., and Enneking, W.F. Allograft bone decreases in strength in vivo over time. Clin Orthop Relat Res 435, 36, 2005.
33. Nunamaker, D.M. Experimental models of fracture repair. Clin Orthop Relat Res 355 Suppl, S56, 1998.
34. Zhang, X., Naik, A., Xie, C., Reynolds, D., Palmer, J., Lin, A., Awad, H., Guldberg, R., Schwarz, E., and O'Keefe, R.J. Periosteal stem cells are essential for bone revitalization and repair. J Musculoskelet Neuronal Interact 5, 360, 2005.
35. Zhang, X., Xie, C., Lin, A.S., Ito, H., Awad, H., Lieberman, J.R., Rubery, P.T., Schwarz, E.M., O'Keefe, R.J., and Guldberg, R.E. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res 20, 2124, 2005.
36. Ito, H., Koefoed, M., Tiyapatanaputi, P., Gromov, K., Goater, J.J., Carmouche, J., Zhang, X., Rubery, P.T., Rabinowitz, J., Samulski, R.J., Nakamura, T., Soballe, K., O'Keefe, R.J., Boyce, B.F., and Schwarz, E.M. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med 11, 291, 2005.
37. Street, J., Bao, M., deGuzman, L., Bunting, S., Peale, F.V., Jr., Ferrara, N., Steinmetz, H., Hoeffel, J., Cleland, J.L., Daugherty, A., van Bruggen, N., Redmond, H.P., Carano, R.A., and Filvaroff, E.H. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99, 9656, 2002.
38. Street, J., Winter, D., Wang, J.H., Wakai, A., McGuinness, A., and Redmond, H.P. Is human fracture hematoma inherently angiogenic? Clin Orthop Relat Res 378, 224, 2000.
39. Reynolds, D.G., Zhang, X., Rubery, P.T., O'Keefe, R.J., Lerner, A.L., Schwarz, E.M., and Awad, H.A. Mechanical strength of mouse femoral allografts declines over time after transplantation, 52nd Annual meeting of the Orthopaedic Research Society, Chicago, IL, 2006.
40. Wheeler, D.L., Haynie, J.L., Berrey, H., Scarborough, M., and Enneking, W. Biomechanical evaluation of retrieved massive allografts: preliminary results. Biomed Sci Instrum 37, 251, 2001.
41. Bruder, S.P., Fink, D.J., and Caplan, A.I. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 56, 283, 1994.
42. Bruder, S.P., Jaiswal, N., Ricalton, N.S., Mosca, J.D., Kraus, K.H., and Kadiyala, S. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res 355 Suppl, S247, 1998.
43. Caplan, A.I., and Bruder, S.P. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 7, 259, 2001.
44. Bruder, S.P., Kurth, A.A., Shea, M., Hayes, W.C., Jaiswal, N., and Kadiyala, S. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 16, 155, 1998.
45. Bruder, S.P., Kraus, K.H., Goldberg, V.M., and Kadiyala, S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 80, 985, 1998.
46. Kubler, N., Michel, C., Zoller, J., Bill, J., Muhling, J., and Reuther, J. Repair of human skull defects using osteoinductive bone alloimplants. J Craniomaxillofac Surg 23, 337, 1995.
47. Iwata, H., Hanamura, H., Kaneko, M., Yasuhara, N., Terashima, Y., Kajino, G., Ida, K., Mabuchi, Y., and Nakagawa, M. Chemosterilized autolyzed antigen-extracted allogeneic (AAA) bone matrix gelatin for repair of defects from excision of benign bone tumors: a preliminary report. Clin Orthop Relat Res 154, 150, 1981.
48. Urist, M.R., and Dawson, E. Intertransverse process fusion with the aid of chemosterilized autolyzed antigen-extracted allogeneic (AAA) bone. Clin Orthop Relat Res 154, 97, 1981.
49. De Biase, P., and Capanna, R. Clinical applications of BMPs. Injury 36 Suppl 3, S43, 2005.
50. Murakami, N., Saito, N., Takahashi, J., Ota, H., Horiuchi, H., Nawata, M., Okada, T., Nozaki, K., and Takaoka, K. Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier. Biomaterials 24, 2153, 2003.
51. Derner, R., and Anderson, A.C. The bone morphogenic protein. Clin Podiatr Med Surg North Am 22, 607, 2005.
52. Baltzer, A.W., Lattermann, C., Whalen, J.D., Wooley, P., Weiss, K., Grimm, M., Ghivizzani, S.C., Robbins, P.D., and Evans, C.H. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther 7, 734, 2000.
53. Dragoo, J.L., Choi, J.Y., Lieberman, J.R., Huang, J., Zuk, P.A., Zhang, J., Hedrick, M.H., and Benhaim, P. Bone induction by BMP-2 transduced stem cells derived from human fat. J Orthop Res 21, 622, 2003.
54. Lieberman, J.R., Le, L.Q., Wu, L., Finerman, G.A., Berk, A., Witte, O.N., and Stevenson, S. Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res 16, 330, 1998.
55. Chen, Y., Luk, K.D., Cheung, K.M., Xu, R., Lin, M.C., Lu, W.W., Leong, J.C., and Kung, H.F. Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Gene Ther 10, 1345, 2003.
56. Rajagopalan, S., Shah, M., Luciano, A., Crystal, R., and Nabel, E.G. Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve. Circulation 104, 753, 2001.
57. Franceschi, R.T. Biological approaches to bone regeneration by gene therapy. J Dent Res 84, 1093, 2005.
58. Lieberman, J.R., Daluiski, A., Stevenson, S., Wu, L., McAllister, P., Lee, Y.P., Kabo, J.M., Finerman, G.A., Berk, A.J., and Witte, O.N. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am 81, 905, 1999.
59. Kofron, M.D., and Laurencin, C.T. Bone tissue engineering by gene delivery. Adv Drug Deliv Rev 58, 555, 2006.
60. Bonadio, J., Smiley, E., Patil, P., and Goldstein, S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 5, 753, 1999.
61. Muruve, D.A. The innate immune response to adenovirus vectors. Hum Gene Ther 15, 1157, 2004.
62. Atkinson, E.M. American Society of Gene Therapy - Third Annual Meeting. IDrags 3, 1009, 2000.
63. Monahan, P.E., and Samulski, R.J. Adeno-associated virus vectors for gene therapy: more pros than cons? Mol Med Today 6, 433, 2000.
64. Malik, A.K., Monahan, P.E., Allen, D.L., Chen, B.G., Samulski, R.J., and Kurachi, K. Kinetics of recombinant adeno-associated virus-mediated gene transfer. J Virol 74, 3555, 2000.
65. Monahan, P.E., and Samulski, R.J. AAV vectors: is clinical success on the horizon? Gene Ther 7, 24, 2000.
66. Schwarz, E.M. The adeno-associated virus vector for orthopaedic gene therapy. Clin Orthop Relat Res 379 Suppl, S31, 2000.
67. Ulrich-Vinther, M., Maloney, M.D., Goater, J.J., Soballe, K., Goldring, M.B., O'Keefe, R.J., and Schwarz, E.M. Light-activated gene transduction enhances adeno-associated virusvector-mediated gene expression in human articular chondrocytes. Arthritis Rheum 46, 2095, 2002.
68. Ulrich-Vinther, M., Carmody, E.E., Goater, J.J., K, S.b., O'Keefe, R.J., and Schwarz, E.M. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. J Bone Joint Surg Am 84-A, 1405, 2002.
69. Goater, J., Muller, R., Kollias, G., Firestein, G.S., Sanz, I., O'Keefe, R.J., and Schwarz, E.M. Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis. J Rheumatol 27, 983, 2000.
70. Wang, J.C., Kanim, L.E., Yoo, S., Campbell, P.A., Berk, A.J., and Lieberman, J.R. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J Bone Joint Surg Am 85-A, 905, 2003.
71. Hidaka, C., Goshi, K., Rawlins, B., Boachie-Adjei, O., and Crystal, R.G. Enhancement of spine fusion using combined gene therapy and tissue engineering BMP-7-expressing bone marrow cells and allograft bone. Spine 28, 2049, 2003.
72. Rundle, C.H., Miyakoshi, N., Kasukawa, Y., Chen, ST., Sheng, M.H., Wergedal, J.E., Lau, K.H., and Baylink, D.J. In vivo bone formation in fracture repair induced by direct retroviral-based gene therapy with bone morphogenetic protein-4. Bone 32, 591, 2003.
73. Wright, V., Peng, H., Usas, A., Young, B., Gearhart, B., Cummins, J., and Huard, J. BMP4- expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Mol Ther 6, 169, 2002.
74. Shen, H.C., Peng, H., Usas, A., Gearhart, B., Fu, F.H., and Huard, J. Structural and functional healing of critical-size segmental bone defects by transduced muscle-derived cells expressing BMP4. J Gene Med 6, 984, 2004.
75. Sugiyama, O., An, D.S., Kung, S.P., Feeley, B.T., Gamradt, S., Liu, N.Q., Chen, I.S., and Lieberman, J.R. Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Mol Ther 11, 390, 2005.
76. Moutsatsos, I.K., Turgeman, G., Zhou, S., Kurkalli, B.G., Pelled, G., Tzur, L., Kelley, P., Stumm, N., Mi, S., Muller, R., Zilberman, Y., and Gazit, D. Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 3, 449, 2001.
77. Gafni, Y., Pelled, G., Zilberman, Y., Turgeman, G., Apparailly, F., Yotvat, H., Galun, E., Gazit, Z., Jorgensen, C., and Gazit, D. Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. Mol Ther 9, 587, 2004.
78. Koefoed, M., Ito, H., Gromov, K., Reynolds, D.G., Awad, H.A., Rubery, P.T., Ulrich-Vinther, M., Soballe, K., Guldberg, R.E., Lin, A., O'Keefe, R.J., Zhang, X., and Schwarz, E.M. Biological effects of rAAV-caAlk2 coating on structural allograft healing. Mol Ther 12, 212, 2005.
79. Urist, M.R. Bone: formation by autoinduction. Science 150, 893, 1965.
80. Kloen, P., Di Paola, M., Borens, O., Richmond, J., Perino, G., Helfet, D.L., and Goumans, M.J. BMP signaling components are expressed in human fracture callus. Bone 33, 362, 2003.
81. Nilsson, O.S., Urist, M.R., Dawson, E.G., Schmalzried, T.P., and Finerman, G.A. Bone repair induced by bone morphogenetic protein in ulnar defects in dogs. J Bone Joint Surg Br 68, 635, 1986.
82. Takagi, K., and Urist, M.R. The role of bone marrow in bone morphogenetic protein-induced repair of femoral massive diaphyseal defects. Clin Orthop Relat Res 171, 224, 1982.
83. Johnson, E.E., Urist, M.R., and Finerman, G.A. Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. Clin Orthop Relat Res 230, 257, 1988.
84. Teixeira, J.O., and Urist, M.R. Bone morphogenetic protein induced repair of compartmentalized segmental diaphyseal defects. Arch Orthop Trauma Surg 117, 27, 1998.
85. Hak, D.J., Makino, T., Niikura, T., Hazelwood, S.J., Curtiss, S., and Reddi, A.H. Recombinant human BMP-7 effectively prevents non-union in both young and old rats. J Orthop Res 24, 11, 2006.
86. Granjeiro, J.M., Oliveira, R.C., Bustos-Valenzuela, J.C., Sogayar, M.C., and Taga, R. Bone morphogenetic proteins: from structure to clinical use. Braz J Med Biol Res 38, 1463, 2005.
87. Bax, B.E., Wozney, J.M., and Ashhurst, D.E. Bone morphogenetic protein-2 increases the rate of callus formation after fracture of the rabbit tibia. Calcif Tissue Int 65, 83, 1999.
88. Wang, E.A. Bone morphogenetic proteins (BMPs): therapeutic potential in healing bony defects. Trends Biotechnol 11, 379, 1993.
89. Khan, S.N., Bostrom, M.P., and Lane, J.M. Bone growth factors. Orthop Clin North Am 31, 375, 2000.
90. Bostrom, M.P., Saleh, K.J., and Einhorn, T.A. Osteoinductive growth factors in preclinical fracture and long bone defects models. Orthop Clin North Am 30, 647, 1999.
91. Kloen, P., Doty, S.B., Gordon, E., Rubel, I.F., Goumans, M.J., and Helfet, D.L. Expression and activation of the BMP-signaling components in human fracture nonunions. J Bone Joint Surg Am 84-A, 1909, 2002.
92. Zhang, D., Schwarz, E.M., Rosier, R.N., Zuscik, M.J., Puzas, J.E., and O'Keefe, R.I. ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development. J Bone Miner Res 18, 1593, 2003.
93. ten Dijke, P., Yamashita, H., Ichijo, H., Franzen, P., Laiho, M., Miyazono, K., and Heldin, C.H. Characterization of type I receptors for transforming growth factor-beta and activin. Science 264, 101, 1994.
94. Attisano, L., Carcamo, J., Ventura, F., Weis, F.M., Massague, J., and Wrana, J.L. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75, 671, 1993.
95. Yamashita, H., ten Dijke, P., Huylebroeck, D., Sampath, T.K., Andries, M., Smith, J.C., Heldin, C.H., and Miyazono, K. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J Cell Biol 130, 217, 1995.
96. ten Dijke, P., Yamashita, H., Sampath, T.K., Reddi, A.H., Estevez, M., Riddle, D.L., Ichijo, H., Heldin, C.H., and Miyazono, K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 269, 16985, 1994.
97. Chen, Y.G., and Massague, J. Smad1 recognition and activation by the ALK1 group of transforming growth factor-beta family receptors. J Biol Chem 274, 3672, 1999.
98. Chen, Y., Bhushan, A., and Vale, W. Smad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinase. Proc Natl Acad Sci USA 94, 12938, 1997.
99. Tsuchida, K., Mathews, L.S., and Vale, W.W. Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor. Proc Natl Acad Sci USA 90, 11242, 1993.
100. Shore, E.M., Xu, M., Feldman, G.J., Fenstermacher, D.A., Brown, M.A., and Kaplan, F.S. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38, 525, 2006.
101. Carlevaro, M.F., Cermelli, S., Cancedda, R., and Descalzi Cancedda, F. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 113 (Pt 1), 59, 2000.
102. Maes, C., Carmeliet, P., Moermans, K., Stockmans, I., Smets, N., Collen, D., Bouillon, R., and Carmeliet, G. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mech Dev 111, 61, 2002.
103. Rabie, A.B., Leung, F.Y., Chayanupatkul, A., and Hagg, U. The correlation between neovascularization and bone formation in the condyle during forward mandibular positioning. Angle Orthod 72, 431, 2002.
104. Zelzer, E., McLean, W., Ng, Y.S., Fukai, N., Reginato, A.M., Lovejoy, S., D'Amore, P.A., and Olsen, B.R. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129, 1893, 2002.
105. Zelzer, E., and Olsen, B.R. Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair. Curr Top Dev Biol 65, 169, 2005.
106. Gerber, H.P., Vu, T.H., Ryan, A.M., Kowalski, J., Werb, Z., and Ferrara, N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5, 623, 1999.
107. Vale, P.R., Isner, J.M., and Rosenfield, K. Therapeutic angiogenesis in critical limb and myocardial ischemia. J Interv Cardiol 14, 511, 2001.
108. Ferrara, N., and Alitalo, K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 5, 1359, 1999.
109. Laham, R. Angiogenesis (clinical trials). Can J Cardiol 17 Suppl A, 29A, 2001.
110. Manley, P.W., Martiny-Baron, G., Schlaeppi, J.M., and Wood, J.M. Therapies directed at vascular endothelial growth factor. Expert Opin Investig Drugs 11, 1715, 2002.
111. Rutanen, J., Rissanen, T.T., Kivela, A., Vajanto, I., and Yla-Herttuala, S. Clinical applications of vascular gene therapy. Curr Cardiol Rep 3, 29, 2001.
112. Simons, M., Bonow, R.O., Chronos, N.A., Cohen, D.J., Giordano, F.J., Hammond, H.K., Laham, R.J., Li, W., Pike, M., Sellke, F.W., Stegmann, T.J., Udelson, J.E., and Rosengart, T.K. Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary. Circulation 102, E73, 2000.
113. Thompson, W.D., Li, W.W., and Maragoudakis, M. The clinical manipulation of angiogenesis: pathology, side-effects, surprises, and opportunities with novel human therapies. J Pathol 187, 503, 1999.
114. Boyle, W.J., Simonet, W.S., and Lacey, D.L. Osteoclast differentiation and activation. Nature 423, 337, 2003.
115. Theill, L.E., Boyle, W.J., and Penninger, J.M. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 20, 795, 2002.
116. Shalhoub, V., Elliott, G., Chiu, L., Manoukian, R., Kelley, M., Hawkins, N., Davy, E., Shimamoto, G., Beck, J., Kaufman, S.A., Van, G., Scully, S., Qi, M., Grisanti, M., Dunstan, C., Boyle, W.J., and Lacey, D.L. Characterization of osteoclast precursors in human blood. Br J Haematol 111, 501, 2000.
117. Li, J., Sarosi, I., Yan, X.Q., Morony, S., Capparelli, C., Tan, H.L., McCabe, S., Elliott, R., Scully, S., Van, G., Kaufman, S., Juan, S.C., Sun, Y., Tarpley, J., Martin, L., Christensen, K., McCabe, J., Kostenuik, P., Hsu, H., Fletcher, F., Dunstan, C.R., Lacey, D.L., and Boyle, W.J. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 97, 1566, 2000.
118. Hsu, H., Lacey, D.L., Dunstan, C.R., Solovyev, I., Colombero, A., Timms, E., Tan, H.L., Elliott, G., Kelley, M.J., Sarosi, I., Wang, L., Xia, X.Z., Elliott, R., Chiu, L., Black, T., Scully, S., Capparelli, C., Morony, S., Shimamoto, G., Bass, M.B., and Boyle, W.J. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96, 3540, 1999.